News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Jarushka Naidoo: Phase Ib Trial on Ivonescimab with Etoposide Plus Carboplatin in 1st line ES SCLC
Jarushka Naidoo/X
Feb 11, 2025, 08:47

Jarushka Naidoo: Phase Ib Trial on Ivonescimab with Etoposide Plus Carboplatin in 1st line ES SCLC

Jarushka Naidoo, Full Professor of Medical Oncology at the Royal College of Surgeons in Ireland, shared a post on X about a recent paper by Zhiwei Chen et al. published in the Journal of Thoracic Oncology:

“Phase Ib Trial Ivonescimab (PD-1/VEGF bispecific)+Plt/Etop in 1L ES SCLC in Journal of Thoracic Oncology:

  • Ivo (3 dose levels)+plt/etopx4 – ivo maintenance
  • 35pts, ORR 80%, DCR 91%
  • g3+ TRAEs 60% (low ANC, WBC, Hb)

Intriguing. VEGF is not a traditional SCLC target.”

“Brief Report: Ivonescimab Combined With Etoposide Plus Carboplatin as First-Line Treatment for Extensive-Stage SCLC: Results of a Phase 1b Clinical Trial”

Authors: Zhiwei Chen, Lin Wu, Qiming Wang, Xiao Xu, Shun Lu et al.

Jarushka Naidoo: Phase Ib Trial on Ivonescimab with Etoposide Plus Carboplatin in 1st line ES SCLC

More posts featuring Jarushka Naidoo.

cancer carboplatin etoposide ivonescimab Jarushka Naidoo Lin Wu OncoDaily Oncology Qiming Wang SCLC Shun Lu Xiao Xu Zhiwei Chen
Special Coverage
Insight
Feb 11, 2025, 08:47
Jarushka Naidoo: Phase Ib Trial on Ivonescimab with Etoposide Plus Carboplatin in 1st line ES SCLC
Science
Feb 11, 2025, 08:43
Gustavo Viani: Should we rethink ADT omission in dose-escalated RT?
Science
Feb 11, 2025, 08:41
Jasmin Hundal: The impact of breast cancer treatments on fertility in young women
Blog
Feb 11, 2025, 08:38
Susanna Fletcher Greer: What does the word ‘love’ mean to you?
Blog
Feb 11, 2025, 08:18
Radiation Oncology Basics in ~10 minutes by Nina Niu Sanford
Science
Feb 11, 2025, 08:15
Carmine Valenza: Platinum rechallenge in patients with platinum-resistant ovarian carcinoma
Blog
Feb 11, 2025, 08:11
Valerie McCormack: The coping strategies of women with breast cancer during chemotherapy
Blog
Feb 11, 2025, 08:11
Guru P. Sonpavde: Honored to present at the FLASCO Puerto Rico Oncology Symposium
Science
Feb 11, 2025, 08:11
Faheema Hasan: History to management of primary and secondary HLH
Blog
Feb 11, 2025, 08:08
Ritu Mittal Garg: Cancer awareness is a year-round commitment
Blog
Feb 11, 2025, 08:06
The Evolving Role of Liquid Biopsy in HR+/HER2- Metastatic Breast Cancer - International Society of Liquid Biopsy
Blog
Feb 11, 2025, 08:06
ICCD 2025 is right around the corner - SIOP